-
Study aim
-
Defining the effect of continuing care model on complications of bone marrow transplantation in patients undergoing bone marrow transplantation.
-
Design
-
In this study, 104 patients with leukemia and study entry conditions who are referred to the Center for Transplantation of Stem Cells at Shariati Hospital in Tehran are selected. In this study, the method used to generate random sequences of patients in the control and case groups is done by stratified randomization. Randomizing at the individual level. By categorizing effective variables such as age, gender, type of transplant, etc., before random assignment, we try to eliminate heterogeneity in groups. Then each randomization class is based on blocking. Allocating patients in the two groups will done randomly on the basis of two blocks. Sequence according to the number of samples in each group, in general 26 blocks.
-
Settings and conduct
-
The study is a clinical trial, two groups, parallel and without blindness in order to defining the effect of continuing care model on complications of bone marrow transplantation in patients undergoing bone marrow transplantation. The study population includes all patients that undergoing stem cell transplantation in the center of bone marrow transplantation at Shariati Hospital in Tehran.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patient is undergoing stem cell transplantation, Satisfaction of the patient to participate in the study, Have at least reading and writing skills, Age between 15 and 60 years. ؛ Exclusion criteria: Patients with major thalassemia or immunodeficiency disorders, Lack of access to methods of communication such as telephone,The patient is a member of the treatment team. verbal, perceptual and psychological disorders
-
Intervention groups
-
We use a continuous care model in the education of transplanted patients. The control group will receive routine care and routine training, and Patients in the intervention group will receive routine care, continuing education in order to improve nutrition, relieve the symptoms and complications of Graft versus host disease, control infection and reduce the days of admission and anxiety control on an individual and face-to-face basis, based on a continuous care model for 3 months
-
Main outcome variables
-
Consequences such as the number of hospital days, degree of oral mucositis, Graft versus host disease grade, clinical and laboratory signs and symptoms of infection, and severity of anxiety are measured every 4 weeks.